Global Rabeprazole Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 117

Published Date: 05 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion.

According to our (Global Info Research) latest study, the global Rabeprazole market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Rabeprazole market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Rabeprazole market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabeprazole market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabeprazole market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rabeprazole market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rabeprazole
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rabeprazole market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eisai, Aytu Therapeutics, Avadel Pharmaceuticals, Zuche Pharmaceuticals and Cardinal Health, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Rabeprazole market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Tablet
    Capsule

Market segment by Application
    Peptic Ulcer Disease
    Gastroesophageal Reflux Disease
    Others

Major players covered
    Eisai
    Aytu Therapeutics
    Avadel Pharmaceuticals
    Zuche Pharmaceuticals
    Cardinal Health
    Jamp Pharma Corporation
    Dominion Pharmacal
    Apotex Corporation
    Angita Pharma
    Mylan
    Novartis
    Livzon Pharmaceutical
    C&O Pharmaceutical
    Sinepharma
    Aosaikang
    Rundu Pharma
    Luoxin Pharmacutical

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rabeprazole product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rabeprazole, with price, sales, revenue and global market share of Rabeprazole from 2018 to 2023.
Chapter 3, the Rabeprazole competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rabeprazole breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Rabeprazole market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rabeprazole.
Chapter 14 and 15, to describe Rabeprazole sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Rabeprazole
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Rabeprazole Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Tablet
        1.3.3 Capsule
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Rabeprazole Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Peptic Ulcer Disease
        1.4.3 Gastroesophageal Reflux Disease
        1.4.4 Others
    1.5 Global Rabeprazole Market Size & Forecast
        1.5.1 Global Rabeprazole Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Rabeprazole Sales Quantity (2018-2029)
        1.5.3 Global Rabeprazole Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Eisai
        2.1.1 Eisai Details
        2.1.2 Eisai Major Business
        2.1.3 Eisai Rabeprazole Product and Services
        2.1.4 Eisai Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Eisai Recent Developments/Updates
    2.2 Aytu Therapeutics
        2.2.1 Aytu Therapeutics Details
        2.2.2 Aytu Therapeutics Major Business
        2.2.3 Aytu Therapeutics Rabeprazole Product and Services
        2.2.4 Aytu Therapeutics Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Aytu Therapeutics Recent Developments/Updates
    2.3 Avadel Pharmaceuticals
        2.3.1 Avadel Pharmaceuticals Details
        2.3.2 Avadel Pharmaceuticals Major Business
        2.3.3 Avadel Pharmaceuticals Rabeprazole Product and Services
        2.3.4 Avadel Pharmaceuticals Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Avadel Pharmaceuticals Recent Developments/Updates
    2.4 Zuche Pharmaceuticals
        2.4.1 Zuche Pharmaceuticals Details
        2.4.2 Zuche Pharmaceuticals Major Business
        2.4.3 Zuche Pharmaceuticals Rabeprazole Product and Services
        2.4.4 Zuche Pharmaceuticals Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Zuche Pharmaceuticals Recent Developments/Updates
    2.5 Cardinal Health
        2.5.1 Cardinal Health Details
        2.5.2 Cardinal Health Major Business
        2.5.3 Cardinal Health Rabeprazole Product and Services
        2.5.4 Cardinal Health Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Cardinal Health Recent Developments/Updates
    2.6 Jamp Pharma Corporation
        2.6.1 Jamp Pharma Corporation Details
        2.6.2 Jamp Pharma Corporation Major Business
        2.6.3 Jamp Pharma Corporation Rabeprazole Product and Services
        2.6.4 Jamp Pharma Corporation Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Jamp Pharma Corporation Recent Developments/Updates
    2.7 Dominion Pharmacal
        2.7.1 Dominion Pharmacal Details
        2.7.2 Dominion Pharmacal Major Business
        2.7.3 Dominion Pharmacal Rabeprazole Product and Services
        2.7.4 Dominion Pharmacal Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Dominion Pharmacal Recent Developments/Updates
    2.8 Apotex Corporation
        2.8.1 Apotex Corporation Details
        2.8.2 Apotex Corporation Major Business
        2.8.3 Apotex Corporation Rabeprazole Product and Services
        2.8.4 Apotex Corporation Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Apotex Corporation Recent Developments/Updates
    2.9 Angita Pharma
        2.9.1 Angita Pharma Details
        2.9.2 Angita Pharma Major Business
        2.9.3 Angita Pharma Rabeprazole Product and Services
        2.9.4 Angita Pharma Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Angita Pharma Recent Developments/Updates
    2.10 Mylan
        2.10.1 Mylan Details
        2.10.2 Mylan Major Business
        2.10.3 Mylan Rabeprazole Product and Services
        2.10.4 Mylan Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Mylan Recent Developments/Updates
    2.11 Novartis
        2.11.1 Novartis Details
        2.11.2 Novartis Major Business
        2.11.3 Novartis Rabeprazole Product and Services
        2.11.4 Novartis Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Novartis Recent Developments/Updates
    2.12 Livzon Pharmaceutical
        2.12.1 Livzon Pharmaceutical Details
        2.12.2 Livzon Pharmaceutical Major Business
        2.12.3 Livzon Pharmaceutical Rabeprazole Product and Services
        2.12.4 Livzon Pharmaceutical Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Livzon Pharmaceutical Recent Developments/Updates
    2.13 C&O Pharmaceutical
        2.13.1 C&O Pharmaceutical Details
        2.13.2 C&O Pharmaceutical Major Business
        2.13.3 C&O Pharmaceutical Rabeprazole Product and Services
        2.13.4 C&O Pharmaceutical Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 C&O Pharmaceutical Recent Developments/Updates
    2.14 Sinepharma
        2.14.1 Sinepharma Details
        2.14.2 Sinepharma Major Business
        2.14.3 Sinepharma Rabeprazole Product and Services
        2.14.4 Sinepharma Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Sinepharma Recent Developments/Updates
    2.15 Aosaikang
        2.15.1 Aosaikang Details
        2.15.2 Aosaikang Major Business
        2.15.3 Aosaikang Rabeprazole Product and Services
        2.15.4 Aosaikang Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Aosaikang Recent Developments/Updates
    2.16 Rundu Pharma
        2.16.1 Rundu Pharma Details
        2.16.2 Rundu Pharma Major Business
        2.16.3 Rundu Pharma Rabeprazole Product and Services
        2.16.4 Rundu Pharma Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Rundu Pharma Recent Developments/Updates
    2.17 Luoxin Pharmacutical
        2.17.1 Luoxin Pharmacutical Details
        2.17.2 Luoxin Pharmacutical Major Business
        2.17.3 Luoxin Pharmacutical Rabeprazole Product and Services
        2.17.4 Luoxin Pharmacutical Rabeprazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Luoxin Pharmacutical Recent Developments/Updates

3 Competitive Environment: Rabeprazole by Manufacturer
    3.1 Global Rabeprazole Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Rabeprazole Revenue by Manufacturer (2018-2023)
    3.3 Global Rabeprazole Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Rabeprazole by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Rabeprazole Manufacturer Market Share in 2022
        3.4.2 Top 6 Rabeprazole Manufacturer Market Share in 2022
    3.5 Rabeprazole Market: Overall Company Footprint Analysis
        3.5.1 Rabeprazole Market: Region Footprint
        3.5.2 Rabeprazole Market: Company Product Type Footprint
        3.5.3 Rabeprazole Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Rabeprazole Market Size by Region
        4.1.1 Global Rabeprazole Sales Quantity by Region (2018-2029)
        4.1.2 Global Rabeprazole Consumption Value by Region (2018-2029)
        4.1.3 Global Rabeprazole Average Price by Region (2018-2029)
    4.2 North America Rabeprazole Consumption Value (2018-2029)
    4.3 Europe Rabeprazole Consumption Value (2018-2029)
    4.4 Asia-Pacific Rabeprazole Consumption Value (2018-2029)
    4.5 South America Rabeprazole Consumption Value (2018-2029)
    4.6 Middle East and Africa Rabeprazole Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Rabeprazole Sales Quantity by Type (2018-2029)
    5.2 Global Rabeprazole Consumption Value by Type (2018-2029)
    5.3 Global Rabeprazole Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Rabeprazole Sales Quantity by Application (2018-2029)
    6.2 Global Rabeprazole Consumption Value by Application (2018-2029)
    6.3 Global Rabeprazole Average Price by Application (2018-2029)

7 North America
    7.1 North America Rabeprazole Sales Quantity by Type (2018-2029)
    7.2 North America Rabeprazole Sales Quantity by Application (2018-2029)
    7.3 North America Rabeprazole Market Size by Country
        7.3.1 North America Rabeprazole Sales Quantity by Country (2018-2029)
        7.3.2 North America Rabeprazole Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Rabeprazole Sales Quantity by Type (2018-2029)
    8.2 Europe Rabeprazole Sales Quantity by Application (2018-2029)
    8.3 Europe Rabeprazole Market Size by Country
        8.3.1 Europe Rabeprazole Sales Quantity by Country (2018-2029)
        8.3.2 Europe Rabeprazole Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Rabeprazole Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Rabeprazole Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Rabeprazole Market Size by Region
        9.3.1 Asia-Pacific Rabeprazole Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Rabeprazole Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Rabeprazole Sales Quantity by Type (2018-2029)
    10.2 South America Rabeprazole Sales Quantity by Application (2018-2029)
    10.3 South America Rabeprazole Market Size by Country
        10.3.1 South America Rabeprazole Sales Quantity by Country (2018-2029)
        10.3.2 South America Rabeprazole Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Rabeprazole Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Rabeprazole Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Rabeprazole Market Size by Country
        11.3.1 Middle East & Africa Rabeprazole Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Rabeprazole Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Rabeprazole Market Drivers
    12.2 Rabeprazole Market Restraints
    12.3 Rabeprazole Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Rabeprazole and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Rabeprazole
    13.3 Rabeprazole Production Process
    13.4 Rabeprazole Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Rabeprazole Typical Distributors
    14.3 Rabeprazole Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Rabeprazole Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Rabeprazole Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Eisai Basic Information, Manufacturing Base and Competitors
    Table 4. Eisai Major Business
    Table 5. Eisai Rabeprazole Product and Services
    Table 6. Eisai Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Eisai Recent Developments/Updates
    Table 8. Aytu Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 9. Aytu Therapeutics Major Business
    Table 10. Aytu Therapeutics Rabeprazole Product and Services
    Table 11. Aytu Therapeutics Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Aytu Therapeutics Recent Developments/Updates
    Table 13. Avadel Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 14. Avadel Pharmaceuticals Major Business
    Table 15. Avadel Pharmaceuticals Rabeprazole Product and Services
    Table 16. Avadel Pharmaceuticals Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Avadel Pharmaceuticals Recent Developments/Updates
    Table 18. Zuche Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 19. Zuche Pharmaceuticals Major Business
    Table 20. Zuche Pharmaceuticals Rabeprazole Product and Services
    Table 21. Zuche Pharmaceuticals Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Zuche Pharmaceuticals Recent Developments/Updates
    Table 23. Cardinal Health Basic Information, Manufacturing Base and Competitors
    Table 24. Cardinal Health Major Business
    Table 25. Cardinal Health Rabeprazole Product and Services
    Table 26. Cardinal Health Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Cardinal Health Recent Developments/Updates
    Table 28. Jamp Pharma Corporation Basic Information, Manufacturing Base and Competitors
    Table 29. Jamp Pharma Corporation Major Business
    Table 30. Jamp Pharma Corporation Rabeprazole Product and Services
    Table 31. Jamp Pharma Corporation Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Jamp Pharma Corporation Recent Developments/Updates
    Table 33. Dominion Pharmacal Basic Information, Manufacturing Base and Competitors
    Table 34. Dominion Pharmacal Major Business
    Table 35. Dominion Pharmacal Rabeprazole Product and Services
    Table 36. Dominion Pharmacal Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Dominion Pharmacal Recent Developments/Updates
    Table 38. Apotex Corporation Basic Information, Manufacturing Base and Competitors
    Table 39. Apotex Corporation Major Business
    Table 40. Apotex Corporation Rabeprazole Product and Services
    Table 41. Apotex Corporation Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Apotex Corporation Recent Developments/Updates
    Table 43. Angita Pharma Basic Information, Manufacturing Base and Competitors
    Table 44. Angita Pharma Major Business
    Table 45. Angita Pharma Rabeprazole Product and Services
    Table 46. Angita Pharma Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Angita Pharma Recent Developments/Updates
    Table 48. Mylan Basic Information, Manufacturing Base and Competitors
    Table 49. Mylan Major Business
    Table 50. Mylan Rabeprazole Product and Services
    Table 51. Mylan Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Mylan Recent Developments/Updates
    Table 53. Novartis Basic Information, Manufacturing Base and Competitors
    Table 54. Novartis Major Business
    Table 55. Novartis Rabeprazole Product and Services
    Table 56. Novartis Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Novartis Recent Developments/Updates
    Table 58. Livzon Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 59. Livzon Pharmaceutical Major Business
    Table 60. Livzon Pharmaceutical Rabeprazole Product and Services
    Table 61. Livzon Pharmaceutical Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Livzon Pharmaceutical Recent Developments/Updates
    Table 63. C&O Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 64. C&O Pharmaceutical Major Business
    Table 65. C&O Pharmaceutical Rabeprazole Product and Services
    Table 66. C&O Pharmaceutical Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. C&O Pharmaceutical Recent Developments/Updates
    Table 68. Sinepharma Basic Information, Manufacturing Base and Competitors
    Table 69. Sinepharma Major Business
    Table 70. Sinepharma Rabeprazole Product and Services
    Table 71. Sinepharma Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Sinepharma Recent Developments/Updates
    Table 73. Aosaikang Basic Information, Manufacturing Base and Competitors
    Table 74. Aosaikang Major Business
    Table 75. Aosaikang Rabeprazole Product and Services
    Table 76. Aosaikang Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Aosaikang Recent Developments/Updates
    Table 78. Rundu Pharma Basic Information, Manufacturing Base and Competitors
    Table 79. Rundu Pharma Major Business
    Table 80. Rundu Pharma Rabeprazole Product and Services
    Table 81. Rundu Pharma Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 82. Rundu Pharma Recent Developments/Updates
    Table 83. Luoxin Pharmacutical Basic Information, Manufacturing Base and Competitors
    Table 84. Luoxin Pharmacutical Major Business
    Table 85. Luoxin Pharmacutical Rabeprazole Product and Services
    Table 86. Luoxin Pharmacutical Rabeprazole Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 87. Luoxin Pharmacutical Recent Developments/Updates
    Table 88. Global Rabeprazole Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 89. Global Rabeprazole Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 90. Global Rabeprazole Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 91. Market Position of Manufacturers in Rabeprazole, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 92. Head Office and Rabeprazole Production Site of Key Manufacturer
    Table 93. Rabeprazole Market: Company Product Type Footprint
    Table 94. Rabeprazole Market: Company Product Application Footprint
    Table 95. Rabeprazole New Market Entrants and Barriers to Market Entry
    Table 96. Rabeprazole Mergers, Acquisition, Agreements, and Collaborations
    Table 97. Global Rabeprazole Sales Quantity by Region (2018-2023) & (K Units)
    Table 98. Global Rabeprazole Sales Quantity by Region (2024-2029) & (K Units)
    Table 99. Global Rabeprazole Consumption Value by Region (2018-2023) & (USD Million)
    Table 100. Global Rabeprazole Consumption Value by Region (2024-2029) & (USD Million)
    Table 101. Global Rabeprazole Average Price by Region (2018-2023) & (US$/Unit)
    Table 102. Global Rabeprazole Average Price by Region (2024-2029) & (US$/Unit)
    Table 103. Global Rabeprazole Sales Quantity by Type (2018-2023) & (K Units)
    Table 104. Global Rabeprazole Sales Quantity by Type (2024-2029) & (K Units)
    Table 105. Global Rabeprazole Consumption Value by Type (2018-2023) & (USD Million)
    Table 106. Global Rabeprazole Consumption Value by Type (2024-2029) & (USD Million)
    Table 107. Global Rabeprazole Average Price by Type (2018-2023) & (US$/Unit)
    Table 108. Global Rabeprazole Average Price by Type (2024-2029) & (US$/Unit)
    Table 109. Global Rabeprazole Sales Quantity by Application (2018-2023) & (K Units)
    Table 110. Global Rabeprazole Sales Quantity by Application (2024-2029) & (K Units)
    Table 111. Global Rabeprazole Consumption Value by Application (2018-2023) & (USD Million)
    Table 112. Global Rabeprazole Consumption Value by Application (2024-2029) & (USD Million)
    Table 113. Global Rabeprazole Average Price by Application (2018-2023) & (US$/Unit)
    Table 114. Global Rabeprazole Average Price by Application (2024-2029) & (US$/Unit)
    Table 115. North America Rabeprazole Sales Quantity by Type (2018-2023) & (K Units)
    Table 116. North America Rabeprazole Sales Quantity by Type (2024-2029) & (K Units)
    Table 117. North America Rabeprazole Sales Quantity by Application (2018-2023) & (K Units)
    Table 118. North America Rabeprazole Sales Quantity by Application (2024-2029) & (K Units)
    Table 119. North America Rabeprazole Sales Quantity by Country (2018-2023) & (K Units)
    Table 120. North America Rabeprazole Sales Quantity by Country (2024-2029) & (K Units)
    Table 121. North America Rabeprazole Consumption Value by Country (2018-2023) & (USD Million)
    Table 122. North America Rabeprazole Consumption Value by Country (2024-2029) & (USD Million)
    Table 123. Europe Rabeprazole Sales Quantity by Type (2018-2023) & (K Units)
    Table 124. Europe Rabeprazole Sales Quantity by Type (2024-2029) & (K Units)
    Table 125. Europe Rabeprazole Sales Quantity by Application (2018-2023) & (K Units)
    Table 126. Europe Rabeprazole Sales Quantity by Application (2024-2029) & (K Units)
    Table 127. Europe Rabeprazole Sales Quantity by Country (2018-2023) & (K Units)
    Table 128. Europe Rabeprazole Sales Quantity by Country (2024-2029) & (K Units)
    Table 129. Europe Rabeprazole Consumption Value by Country (2018-2023) & (USD Million)
    Table 130. Europe Rabeprazole Consumption Value by Country (2024-2029) & (USD Million)
    Table 131. Asia-Pacific Rabeprazole Sales Quantity by Type (2018-2023) & (K Units)
    Table 132. Asia-Pacific Rabeprazole Sales Quantity by Type (2024-2029) & (K Units)
    Table 133. Asia-Pacific Rabeprazole Sales Quantity by Application (2018-2023) & (K Units)
    Table 134. Asia-Pacific Rabeprazole Sales Quantity by Application (2024-2029) & (K Units)
    Table 135. Asia-Pacific Rabeprazole Sales Quantity by Region (2018-2023) & (K Units)
    Table 136. Asia-Pacific Rabeprazole Sales Quantity by Region (2024-2029) & (K Units)
    Table 137. Asia-Pacific Rabeprazole Consumption Value by Region (2018-2023) & (USD Million)
    Table 138. Asia-Pacific Rabeprazole Consumption Value by Region (2024-2029) & (USD Million)
    Table 139. South America Rabeprazole Sales Quantity by Type (2018-2023) & (K Units)
    Table 140. South America Rabeprazole Sales Quantity by Type (2024-2029) & (K Units)
    Table 141. South America Rabeprazole Sales Quantity by Application (2018-2023) & (K Units)
    Table 142. South America Rabeprazole Sales Quantity by Application (2024-2029) & (K Units)
    Table 143. South America Rabeprazole Sales Quantity by Country (2018-2023) & (K Units)
    Table 144. South America Rabeprazole Sales Quantity by Country (2024-2029) & (K Units)
    Table 145. South America Rabeprazole Consumption Value by Country (2018-2023) & (USD Million)
    Table 146. South America Rabeprazole Consumption Value by Country (2024-2029) & (USD Million)
    Table 147. Middle East & Africa Rabeprazole Sales Quantity by Type (2018-2023) & (K Units)
    Table 148. Middle East & Africa Rabeprazole Sales Quantity by Type (2024-2029) & (K Units)
    Table 149. Middle East & Africa Rabeprazole Sales Quantity by Application (2018-2023) & (K Units)
    Table 150. Middle East & Africa Rabeprazole Sales Quantity by Application (2024-2029) & (K Units)
    Table 151. Middle East & Africa Rabeprazole Sales Quantity by Region (2018-2023) & (K Units)
    Table 152. Middle East & Africa Rabeprazole Sales Quantity by Region (2024-2029) & (K Units)
    Table 153. Middle East & Africa Rabeprazole Consumption Value by Region (2018-2023) & (USD Million)
    Table 154. Middle East & Africa Rabeprazole Consumption Value by Region (2024-2029) & (USD Million)
    Table 155. Rabeprazole Raw Material
    Table 156. Key Manufacturers of Rabeprazole Raw Materials
    Table 157. Rabeprazole Typical Distributors
    Table 158. Rabeprazole Typical Customers
List of Figures
    Figure 1. Rabeprazole Picture
    Figure 2. Global Rabeprazole Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Rabeprazole Consumption Value Market Share by Type in 2022
    Figure 4. Tablet Examples
    Figure 5. Capsule Examples
    Figure 6. Global Rabeprazole Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Rabeprazole Consumption Value Market Share by Application in 2022
    Figure 8. Peptic Ulcer Disease Examples
    Figure 9. Gastroesophageal Reflux Disease Examples
    Figure 10. Others Examples
    Figure 11. Global Rabeprazole Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Rabeprazole Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Rabeprazole Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Rabeprazole Average Price (2018-2029) & (US$/Unit)
    Figure 15. Global Rabeprazole Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Rabeprazole Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Rabeprazole by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Rabeprazole Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Rabeprazole Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Rabeprazole Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Rabeprazole Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Rabeprazole Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Rabeprazole Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Rabeprazole Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Rabeprazole Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Rabeprazole Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Rabeprazole Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Rabeprazole Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Rabeprazole Average Price by Type (2018-2029) & (US$/Unit)
    Figure 30. Global Rabeprazole Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Rabeprazole Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Rabeprazole Average Price by Application (2018-2029) & (US$/Unit)
    Figure 33. North America Rabeprazole Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Rabeprazole Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Rabeprazole Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Rabeprazole Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Rabeprazole Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Rabeprazole Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Rabeprazole Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Rabeprazole Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Rabeprazole Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Rabeprazole Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Rabeprazole Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Rabeprazole Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Rabeprazole Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Rabeprazole Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Rabeprazole Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Rabeprazole Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Rabeprazole Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Rabeprazole Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Rabeprazole Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Rabeprazole Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Rabeprazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Rabeprazole Market Drivers
    Figure 74. Rabeprazole Market Restraints
    Figure 75. Rabeprazole Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Rabeprazole in 2022
    Figure 78. Manufacturing Process Analysis of Rabeprazole
    Figure 79. Rabeprazole Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Eisai
Aytu Therapeutics
Avadel Pharmaceuticals
Zuche Pharmaceuticals
Cardinal Health
Jamp Pharma Corporation
Dominion Pharmacal
Apotex Corporation
Angita Pharma
Mylan
Novartis
Livzon Pharmaceutical
C&O Pharmaceutical
Sinepharma
Aosaikang
Rundu Pharma
Luoxin Pharmacutical

Related Reports

Global Rabeprazole Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Rabeprazole Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Rabeprazole market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Rabeprazole Sodium API

Rabeprazole Sodium

Rabeprazole Drug

Rabeprazole

Rabeprazole Sodium Enteric-Coated Capsules

Rabeprazole Sodium Enteric-Coated Tablets

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>